Consult sources: Supportive care in cancer
Video sources:
- Addressing challenges of eating-related distress and social eating and drinking in people affected by cancer
- Addressing Sexual Health Needs of People with Cancer: What Every Health Professional Should Know
- AI for optimizing Toxicity Management of Novel Therapies
- AI in Supportive Care 101
- Antibiotics and Biomarkers Management Optimization in Cancer Patients with Fever (This webinar is made possible by sponsorship provided by Thermo Fisher Scientific)
- Antibody-Drug Conjugates (ADCs)-Induced Nausea and Vomiting and Long-Delayed CINV: New Unmet Medical Needs (This webinar is made possible by sponsorship provided by Helsinn Healthcare SA)
- Avoiding the Cancer Lottery
- Best practices of supportive care in low resource settings
- Bone Metastases and Exercise (BME) Hub - Webinar
- Bridging Health Disparities through Multidisciplinary Supportive Care
- Cancer Associated Thrombosis: Optimising Patient Care and Navigating Clinical Challenges (This webinar has been sponsored by LEO Pharma A/S)
- Cancer Surviorship and Cardiovascular Health
- Cancer Therapy and Diarrhea
- Cancer Therapy and Mouth Sores.. Why it happens and what you can do to reduce the risk
- Cancer Therapy and Nausea
- Cancer Therapy and Your Hair, Skin and Nails
- Cancer/Cancer Treatment-Associated Cognitive Impairment (CICI): Translational Perspectives on Mechanisms and Clinical Impact
- Cardiotoxicity of Emerging Cancer Therapies
- CDK 4/6 Inhibitors: Personalizing Treatment Choices and Optimizing Multidisciplinary Care (This webinar is sponsored by Pfizer)
- Centering Voices: Best Practices for Engaging People with Lived Experience (PWLE) in Supportive Care in Cancer
- Challenges of Antibiotic Management for Cancer Patients in the Emergency Department and Intensive Care Unit (This webinar is made possible by sponsorship provided by Thermo Fisher Scientific)
- Classifying Cancer-Related Faitgue
- Clinical and patient-facing apps to inform oncodermatological supportive care
- Closing the Gap in Geriatric Oncology: Recent Advances and Challenges in Implementing Geriatric Oncology Principles in Routine Cancer Care
- Cultural-Sensitive and resources-tailored vs Evidence-Based
- Digital Health and Palliative Care - Exploring the Role of Telemedicine andArtificial Intelligence
- Digital Health for Older Adults with cancer
- Early-Stage Curative Care: Strategies for Enhancing TreatmentRegimens and Optimizing Chemotherapy Effectiveness (This webinar is made possible by sponsorship provided by Sandoz)
- Educational Series on Oral Mucositis (OM) Induced by Radiotherapy in Head & Neck Cancer (HNC) - Module 1: Oral Mucositis (OM) - More Than Just Mouth Sores
- Educational Series on Oral Mucositis (OM) Induced by Radiotherapy in Head & Neck Cancer (HNC) - Module 2: Clinical Prevention & Management of Radiation Induced Mucositis in Head & Neck Cancer (HNC)
- Effective integration of supportive, palliative, and survivorship care
- Equity Centred Optimization of Virtual Supportive Care
- From Relief to Risk: Navigating Opioid Stigma and Non-medical Opioid Use Among Cancer Patients with Pain
- Gastrointestinal Complications of Immunotherapy and Targeted Agents: Prevention and Treatment Options Webinar - Dr Jervoise Andreyev
- Gastrointestinal Complications of Immunotherapy and Targeted Agents: Prevention and Treatment Options Webinar - Prof Joanne Bowen
- GI Toxicities from Cancer Therapies: Prevention and Management (The webinar is made possible by an unrestricted educational grant from Napo Pharmaceuticals)
- Home Care / Care Close to Home (2024 Annual Meeting Plenary):
Benefits of Hospital at Home in Cancer Care
The Ideal Location for Care Varies According to Disease, Patient and Family Characteristics
Post-Surgical Care at Home: How to Empower Patients and Prepare for Follow-Up Treatment
- Innovative Approaches in the Management of Bone Metastasis: EnhancingPatient Outcomes Through Safe Exercise, Skeletal-Related Event (SREs)Prevention, and Biosimilars (This webinar is made possible by sponsorship provided by Sandoz)
- Innovative Implementation and Quality Improvement in Supportive Care (2024 Annual meeting Plenary)
Innovative supportive care provided to refugee children from Ukraine and their families in Spain.
Digital Health Platforms and Innovative technologies for Pediatric oncologic supportive care
Can Digitalization Improve Consideration to & Research for Older Patient with Cancer?
- Insights to Supportive Skin & Eye Care- Mechanisms for Optimization
- Integrating the Gut Microbiome into Cancer Supportive Care: Advances, Challenges, and Future Opportunities
- Integrative and Interventional Approaches to Cancer Pain
- Lifestyle and behavioral interventions advancing supportive care
- Lifestyle and Behavioral Support in Cancer Care
- Management of Breakthrough Cancer Pain (BTcP) (MASCC and Grünenthal Meds)
- Management of Emerging Toxicities (2024 Annual Meeting Plenary):
Balancing Success with Toxicity: Identification and Management of Novel Agent Toxicity in Breast Cancer Focusing on Antibody Drug Conjugates
Surviving with Immunotoxicity
Adherence, Survivorship, Long-Term Toxicities (Chronic)
- Management of Severe Diarrhea in Patients with Cancer and Clinical Practice Guidelines (This webinar has been made possible by an educational grant from Pharmanovia)
- Managing Menopause After Breast Cancer: Weight, Hot Flashes inRehabilitation (Webinar supported by Nestlé Health Science)
- MASCC & AORTIC Webinar: Navigating the Psychosocial Aspects of Cancer Screening in Women – African Perspective
- MASCC Unmet Needs Assessment of Cancer-Related Cognitive Impairment Impact (MASCC COG-IMPACT) - Video Overview
- MASCC Webinar: Global Disparities in Supportive Care in Cancer, one size does not fit all
- Maximizing access to supportive care for all
- Maximizing Access to Supportive Care for All
- Mechanisms and management of acute toxicities of immune and cell-based therapies
- Meet the Experts: Working Towards Consistent and Meaningful Mucositis Assessment (This Meet the Experts session is made possible by an unrestricted educational grant from Angelini Pharma S.p.A.)
- Modern Peer Support: Advances in peer support for people affected by cancer to ensure access and equity
- Move IT Cancer - The Way to Optimize Cancer Care/Survival: Part 1 Myths and Barriers about Physical Exercise and Cancer
- Move IT Cancer - The Way to Optimize Cancer Care/Survival: Part 2 Panhabilitation in Cancer Care - A Road to Make It Reality
- Mucositis from Antibody–Drug Conjugates and Bispecific Antibodies
- Nausea and Vomiting During Cancer Course: Back to the Future Webinar (This webinar is made possible by an unrestricted educational grant from Helsinn)
- Navigating Constipation Care: New Perspectives in OIC (This webinar is made possible by sponsorship provided by Viatris)
- Navigating Survivorship Care in the 2SLGBTQI+ Community: Barriers to Care and Practical Tips for Health Care Professionals
- Navigating the Evolving Landscape in Early Breast Cancer (eBC):Innovations in Treatment, Patient Support, and Digital Resources (Webinar sponsored by Eli Lilly and Company)
- Neurotoxicity of Emerging Cancer Therapies
- One Size Does Not Fit All: Personalizing Endocrine Therapy Recommendations in Breast Cancer (This webinar is made possible by an educational grant from Biotheranostics Inc., A Hologic Company)
- Opioid Conversion in Adults with Cancer: MASCC-ASCO-AAHPM-HPNA-NICSO Guideline
- Opioid-Induced Constipation (OIC):
Management and Reassessment (MASCC and Grünenthal Meds)
- Opioid-Induced Constipation (OIC): Diagnosis, Assessment, and Clinical Features (MASCC and Grünenthal Meds)
- Optimization of Therapeutic Outcomes for Oncology Patients through Appropriate Skin Care: ISKIMO Expert Consensus (Session supported by La Roche-Posay)
- Optimizing Toxicity Management of Novel Therapies
- Oral Complications of Immunotherapies and TKIs: Similarities and Differences to Conventional Oral Mucositis (MASCC/ISOO webinar).
- Oral infections - Optimizing Toxicity Management
- Outcome Measures in Chemotherapy-induced Peripheral Neurotoxicity (CIPN): From Bedside to Bench-side and Vice Versa
- Patient Partner Session- Advocacy Around the World
- Patient-Centered Communications for Older Adults with Cancer
- Personalized Care of Patients with BrainMetastases: Optimizing Multidisciplinary Care
- Pre-Clinical and Clinical Perspectives of Physical Exercise for the Prevention and Treatment of Chemotherapy-Induced Peripheral Neurotoxicity
- Precision Medicine for Hormone Receptor Positive Breast Cancer: New Therapies and Supportive Care Strategies (Sponsored by Menarini Group/Stemline Therapeutics)
- Precision Oncology: Improving the Understanding of How Molecular Profiling Improves Breast Cancer Care
- Predict Toxicity Risk Factors to Make Excellent Cancer Care Possible
- Prevention of Acute and Persistent Dermatologic Adverse Reactions - How Can Medical Oncologists, Radiation Oncologists and Dermatologists Work Together in Skin, Hair and Nail Toxicities
- Self-Care After Head-and-Neck Radiation
- Self-Care Before Head-and-Neck Radiation
- Self-Care During Active Chemotherapy
- Self-Care During Head-and-Neck Radiation
- Shifting the Dial- Advancing Supportive Care for Nausea
- Social Eating - What Is It, Why It Matters and How It Changes after Head and Neck (HN) Cancer
- Stepped care to improve access to psychosocial interventions
- Stigma and Appearance Care
- Strategies to Safely Target Gut Microbiota in immunocompromised patients
- Supportive Care and Geriatric Oncology:
Common Goals and Common Challenges - A MASCC/SIOG Nursing & Allied Health Interest Group Webinar
- Supportive care for populations in a country who require a different approach
- Tailoring Navigation and Self-Management to Support Older Adults
- The Great Debate: G-CSF Prophylaxis and Febrile Neutropenia Risk Stratification: Personalizing Treatment Choices and Optimizing Multidisciplinary Care
- The impact of cancer-related dermatological toxicities in children, adolescents, and adults
- The Landscape of Pediatric Oncology Guideline Implementation
- Thinking beyond the alimentary tract - shining a light on vaginal and ocular mucositis
- Update in Nutrition & Cachexia in Cancer
Web sources:
- ‘Share your views’—international consultation informs a patient engagement strategy for the Multinational Association of Supportive Care in Cancer
- 15 years supporting adherence to oral anti-cancer treatment: use of the MASCC Oral Agent Teaching Tool (MOATT) worldwide, a review for the future
- 2023 MASCC/ESMO consensus antiemetic guidelines related to integrative and non-pharmacological therapies
- 2023 updated MASCC/ESMO consensus recommendations: controlling nausea and vomiting with chemotherapy of low or minimal emetic potential
- 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents
- 2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
- 2023 Updated MASCC/ESMO Consensus Recommendations: prevention of radiotherapy- and chemoradiotherapy-induced nausea and vomiting
- A call for continued global collaboration and research for the prevention of breast cancer related arm lymphoedema
- A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy
- A Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology Clinical Practice Statement: Management of social eating and drinking challenges in adults with cancer
- A perspective on inequities in the management of radiation dermatitis
- A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
- A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancer
- A Scoping Review of Breakthrough Cancer Pain: Mapping the Evidence Landscape
- A systematic review of dental disease management in cancer patients (This publication has been developed with contributions from MASCC and ISOO)
- A systematic review of oral herpetic viral infections in cancer patients: commonly used outcome measures and interventions (This publication has been developed with contributions from MASCC and ISOO)
- A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies (This publication has been developed with contributions from MASCC and ISOO)
- Accounting for unmet needs resulting from cancer-related cognitive impairment
- Advances and future directions in the use of mobile health in supportive cancer care: proceedings of the 2019 MASCC Annual Meeting symposium
- Anamorelin for the Treatment of Cancer Anorexia-Cachexia Syndrome
- Anticoagulation and bleeding in the cancer patient
- Application of Artificial Intelligence in Symptom Monitoring in Adult Cancer Survivorship: A Systematic Review
- Associations of nutrition impact symptoms with depression in patients with advanced cancer
- Barrier films and dressings for the prevention of acute radiation dermatitis: A systematic review and meta-analysis
- Barrier films or dressings for the prevention of acute radiation dermatitis in breast cancer: a systematic review and network meta-analysis
- Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT)
- Bone Metastases and Exercise (BME) Hub - Additional Resources 1
- Bone Metastases and Exercise (BME) Hub - Additional Resources 2
- Bone Metastases and Exercise (BME) Hub - Additional Resources 3
- Bridging the research to practice gap: a systematic scoping review of implementation of interventions for cancer-related fatigue management
- Cancer care for transgender and gender-diverse people: Practical, literature-driven recommendations from the Multinational Association of Supportive Care in Cancer
- Cancer immunotherapy–related adverse events: causes and challenges
- Cancer survivorship care during COVID-19—perspectives and recommendations from the MASCC survivorship study group
- Cancer Survivorship in the Indo-Pacific: Priorities for Progress
- Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group
- Cancer-related fatigue self-management: a MASCC-endorsed practice framework for healthcare professionals to optimally support cancer survivors
- Care for patients with advanced cancer in the last weeks of life in Brazil
- Catheter-related thrombosis (CRT) in patients with solid tumors: a narrative review and clinical guidance for daily care
- Climate change, climate disasters and oncology care: a descriptive global survey of oncology healthcare professionals
- Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers (This publication has been developed with contributions from MASCC and ISOO)
- Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update
- Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
- Clinicians’ experience with topical benzydamine and morphine for the management of oral mucositis: adverse effects and barriers
- Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
- Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paper
- Defining and addressing loneliness in older adults with cancer: an international Delphi consensus from the Multinational Association of Supportive Care in Cancer Geriatrics Study Group
- Delphi consensus-based recommendations of tools and outcomes for the assessment of radiation dermatitis severity
- Developing alert thresholds and self-management advice for people receiving immune checkpoint inhibitors: a Multinational Association for Supportive Care in Cancer modified Delphi survey
- Development of a self-management support practice framework for addressing cancer-related fatigue: a modified Delphi study
- Development of the MASCC/ISOO clinical practice guidelinesfor mucositis: an overview of the methods
- Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy
- Disparities in telehealth use: How should the supportive care community respond?
- Dual contribution of the gut microbiome to immunotherapy efficacy and toxicity: supportive care implications and recommendations
- Effective Strategies for the Prevention and Mitigation of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia: Optimizing Patient Care
- Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: A MASCC position paper
- Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents
- Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation
- Equity, diversity, and inclusion in the Multinational Association for Supportive Care in Cancer: a global membership survey
- Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners’ knowledge, practices, barriers, and facilitators
- Exercise for people with bone metastases: MASCC endorsed clinical recommendations developed by the International Bone Metastases Exercise Working Group
- Exercise Recommendation for People With Bone Metastases: Expert Consensus for Health Care Providers and Exercise Professionals
- Febrile neutropenia in patients treated with chemotherapy/immune checkpoint inhibition: a MASCC consensus statement
- Financial Toxicity in Cancer Supportive Care: An International Survey
- Framework to leverage physical therapists for the assessment and treatment of chemotherapy-induced peripheral neurotoxicity (CIPN)
- Frequency and characteristics of advanced cancer patients with COVID + ve status among inpatient supportive care consults during the pandemic: experience from a tertiary cancer center
- Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study
- From Pathogenesis to Intervention: The Importance of the Microbiome in Oral Mucositis
- Global disparities in cancer supportive care: An international survey
- Global Initiative to Advance Cancer Navigation for Better Outcomes
- Going beyond (electronic) patient-reported outcomes: harnessing the benefits of smart technology and ecological momentary assessment in cancer survivorship research
- Going beyond the 2023 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting
- Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024 update
- Guideline for the management of fatigue in children and adolescents with cancer or pediatric hematopoietic cell transplant recipients: 2023 update
- Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update
- Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs)
- Inpatient primary prophylaxis of cancer-associated thromboembolism (CAT)
- Introduction to practical aspects of cancer-associated thrombosis and related complications
- Local Sociocultural Practice Specific Financial Toxicity Assessment Tool for Cancer: An Emerging Need
- Low-risk febrile neutropenia: does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?
- Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update
- Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune checkpoint inhibitor endocrinopathies and the role of advanced practice providers in the management of immune-mediated toxicities
- MASCC 2020 recommendations for the management of immune-related adverse events of patients undergoing treatment with immune checkpoint inhibitors
- MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients
- MASCC antiemetic consensus recommendations: resource-limited settings
- MASCC antiemetics in advanced cancer updated guideline
- MASCC clinical practice statement: Prevention and management of acute radiation dermatitis using topical corticosteroids
- MASCC expert opinion/guidance on the use of clinically assisted nutrition in patients with advanced cancer
- MASCC guideline: cannabis for cancer‑related pain and risk of harms and adverse events
- MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer
- MASCC oncodermatology clinical practice statement: prevention and management of acute radiation dermatitis with Mepitel Film and Hydrofilm
- MASCC recommendations on the management of constipation in patients with advanced cancer
- MASCC/ISOO Clinical Practice Guidelines for the Managementof Mucositis Secondary to Cancer Therapy
- MASCC/ISOO clinical practice guidelinesfor the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients
- MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO Clinical Practice Statement: Clinical assessment of salivary gland hypofunction and xerostomia in cancer patients (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO clinical practice statement: Current understanding on controversies in basic oral care in hemato-oncology and hematopoietic cell transplantation (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO Clinical Practice Statement: dental evaluation and management prior to treatment for hematologic malignancies and CAR T-cell therapy (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO Clinical Practice Statement: imaging and clinical laboratory tests in the diagnosis and management of medication-related osteonecrosis of the jaw (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO Clinical Practice Statement: management of oral complications of immunotherapy (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO Clinical Practice Statement: Management of oral complications of targeted therapy
- MASCC/ISOO Clinical Practice Statement: Management of oral manifestations of chronic graft-versus-host-disease (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO Clinical Practice Statement: Management of salivary gland hypofunction and xerostomia in cancer patients (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO Clinical Practice Statement: The risk of secondary oral cancer following hematopoietic cell transplantation (This publication has been developed with contributions from MASCC and ISOO)
- MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer
- Medical management of malignant bowel obstruction in patients with advanced cancer: 2021 MASCC guideline update
- Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline
- Mepitel film for the prevention and treatment of acute radiation dermatitis in breast cancer: A systematic review and meta-analysis of randomized controlled trials
- Mepitel Film for the prevention of acute radiation dermatitis in head and neck cancer: A systematic review and meta-analysis of randomized controlled trials
- Mucositis and Infection in Hematology Patients
- Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitors
- Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity
- Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitors
- Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors
- Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendations
- Multinational Association of Supportive Care in Cancer (MASCC) endorsement and global perspectives on implementation of the American Society of Clinical Oncology and Society of Integrative Oncology (ASCO-SIO) fatigue in adult cancer survivors guideline
- Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer
- Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/guidance on the use of clinically assisted hydration in patients with advanced cancer
- Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression
- Natural and miscellaneous agents for the prevention of acute radiation dermatitis: A systematic review and meta-analysis
- Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy A Phase 3 Randomized Clinical Trial
- Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guideline
- Opioid conversion in adults with cancer: MASCC-ASCO-AAHPM-HPNA-NICSO guideline
- Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review
- Pathogenesis of Oral Toxicities Associated with Targeted Therapy and Immunotherapy
- Patient and Caregiver Education to Support Self‐Efficacy and Self‐Management During Immunotherapy—An Integrative Review
- Patient navigation across the cancer care continuum: An overview of systematic reviews and emerging literature
- Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy
- Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN)
- Patient-reported strategies for prevention and treatment of chemotherapy-induced peripheral neuropathy
- Perceived Barriers Toward Patient-Reported Outcome Implementation in Cancer Care: An International Scoping Survey
- Photobiomodulation therapy for the prevention of acute radiation dermatitis: A systematic review and meta-analysis
- Prediction of mucositis risk secondary to cancer therapy: a systematicreview of current evidence and call to action
- Prevention and management of cardiovascular disease in adults with cancer: an International Cardio-Oncology Society (IC-OS) and Multinational Association of Supportive Care in Cancer (MASCC) clinical practice statement
- Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline
- Prevention of acute and delayed chemotherapy-inducednausea and vomiting in pediatric cancer patients: A clinicalpractice guideline
- Prevention of radiation dermatitis with skin hygiene and washing: A systematic review and meta-analysis
- Primary ambulatory thromboprophylaxis in patients with pancreatic cancer receiving chemotherapy: hope or hype?
- Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
- Quality Survivorship Care for People Affected by Advanced or Metastatic Cancer: A Clinical Oncology Society of Australia Endorsement of the Joint Multinational Association of Supportive Care in Cancer and American Society of Clinical Oncology Care Standards and Practice Recommendations
- Reproductive choice is supportive care in cancer
- Risk factors associated with venous thromboembolism in breast cancer: a narrative review
- Risk stratification for clinical severity of pulmonary embolism in patients with cancer: a narrative review and MASCC clinical guidance for daily care
- Risks, diagnosis, and management of recurrent cancer-associated thrombosis (CAT): a narrative review
- Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline
- Self-management support for cancer-related fatigue: A systematic review
- Serum neurofilament light chain (sNFL) as a predictive biomarker for Chemotherapy-induced peripheral neurotoxicity (CIPN): consideration of current evidence, validation steps, and barriers to CIPN biomarker implementation in clinical practice—a narrative review
- Sex-related differences in eating-related distress experienced by patients with advanced cancer
- Shedding light on the management of acute radiation dermatitis: Insight from the MASCC Oncodermatology Study Group
- Spinal analgesia in cancer pain management—MASCC general practice recommendations
- StrataXRT for the prevention of acute radiation dermatitis in breast cancer: A systematic review and meta-analysis of randomized controlled trials
- Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care—an international Delphi study
- Supportive Care in Pediatric Oncology: Opportunities and Future Directions
- Survey of international pediatric nutritional supportive care practices: a report from the Pediatric Study Group of the Multinational Association of Supportive Care in Cancer (MASCC)
- Survivorship Care for People Affected by Advanced or Metastatic Cancer: Building on the Recent Multinational Association of Supportive Care in Cancer-ASCO Standards and Practice Recommendations
- Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations
- Systematic review and meta-analysis on interventions for radiation dermatitis prevention and management: An overview of the methods
- Systematic review of agents for the management of cancertreatment-related gastrointestinal mucositis and clinical practice guidelines
- Systematic review of anti-inflammatory agentsfor the management of oral mucositis in cancer patients and clinicalpractice guidelines
- Systematic review of antimicrobials, mucosal coating agents,anesthetics, and analgesics for the management of oral mucositisin cancer patients and clinical practice guidelines
- Systematic review of basic oral care for the management of oralmucositis in cancer patients and clinical practice guidelines
- Systematic review of growth factors and cytokinesfor the management of oral mucositis in cancer patients and clinical practice guidelines
- Systematic review of natural and miscellaneous agents,for the management of oral mucositis in cancer patients and clinicalpractice guidelines — part 2: honey, herbal compounds, salivastimulants, probiotics, and miscellaneous agents
- Systematic review of natural and miscellaneous agentsfor the management of oral mucositis in cancer patients and clinicalpractice guidelines—part 1: vitamins, minerals, and nutritionalsupplements
- Systematic review of oral cryotherapy for the management of oralmucositis in cancer patients and clinical practice guidelines
- Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines
- Systematic review of the tools and outcomes for the assessment of acute radiation dermatitis severity
- Telehealth in Oncology: ASCO Standards and Practice Recommendations
- The effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: A systematic review and meta-analysis
- The effect of non-pharmacological interventions on cognitive function in cancer: an overview of systematic reviews
- The efficacy, challenges, and facilitators of telemedicine in post-treatment cancer survivorship care: an overview of systematic reviews
- The impact of the COVID-19 outbreak on supportive care for oral mucositis: current concepts and practice
- The MASCC COG-IMPACT: An unmet needs assessment for cancer-related cognitive impairment impact developed by the Multinational Association of Supportive Care in Cancer
- The MASCC COG-IMPACT: The COSA Endorsement of a MASCC Developed Unmet Needs Assessment Tool for Cancer-Related Cognitive Impairment Impact
- The MASCC Textbook of Cancer Supportive Care and Survivorship
- The MASCC/ISOO Mucositis Guidelines 2019 Update: introductionto the first set of articles
- The MASCC/ISOO mucositis guidelines 2019: the second set of articlesand future directions
- The Multinational Association of Supportive Care in Cancer work after cancer global challenges and solutions white paper: key findings and recommendations
- The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life
- The Rise of Supportive Oncology: A Revolution in Cancer Care
- The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus
- The Supportive Care 2030 Movement - Ambition Statements
- The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners
- Thrombosis, cancer, and COVID-19
- Thrombotic microangiopathy (TMA) in adult patients with solid tumors: a challenging complication in the era of emerging anticancer therapies
- To extract or not extract teeth prior to head and neck radiotherapy? A systematic review and meta-analysis (This publication has been developed with contributions from MASCC and ISOO)
- Topical corticosteroids for the prevention of severe radiation dermatitis: A systematic review and meta-analysis
- Topical non-steroidal agents for the prevention of radiation dermatitis: A systematic review and meta-analysis
- Treatment and secondary prophylaxis of venous thromboembolism in cancer patients
- Treatment of breakthrough and prevention of refractorychemotherapy-induced nausea and vomiting in pediatric cancerpatients: Clinical practice guideline update
- Unmet supportive care needs of people with advanced cancer and their caregivers: A systematic scoping review
- Updated perspectives on the contribution of the microbiome to the pathogenesis of mucositis using the MASCC/ISOO framework
- Use of food restrictions to prevent infections in paediatric patients with cancer and haematopoietic cell transplantation recipients: a systematic review and clinical practice guideline - 2
- What lurks beneath the symptom? Why more basic scientists are needed in cancer supportive care and survivorship research
